Investment
Features
FeesSafety
Academy
More
Pluang+

AI finds critical flaw in Solana's signature update risking 433 metadata accounts

Protocol Fundamentals
17 Sep 2026
Crypto Briefing
View Source
Bearish
AI finds critical flaw in Solana's signature update risking 433 metadata accounts

An autonomous AI agent discovered a vulnerability in Solana's SIMD-0376 proposal, which aims to modernize its signature verification system by adopting the ZIP-215 standard. This flaw allows signing at the zero address, potentially exposing 433 metadata accounts to unauthorized actions. The vulnerability arises because ZIP-215 relaxes certain security checks to enable batch processing, unlike the current Ed25519 standard. Solana developers must now assess their programs for this risk, while the Solana Foundation has yet to comment publicly on the issue.

The critical flaw in Solana's SIMD-0376 proposal is the story's subject, with Pluang market data showing strong cryptocurrency gains today. For readers following the crypto market, here is Pluang's snapshot as of Sep 18, 2026 03:45 WIB: 46 of 50 major cryptocurrencies rose, while 3 fell. Notable movers include COTI at Rp408 with a 35.88% increase, UNI at Rp136.750 up 20.34%, and KSM at Rp78.417 down 16.66%.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
25 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
25 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
25 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
25 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
25 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App